Exploring patients' reasons for discontinuance of heart medications

Journal of Cardiovascular Nursing

Volumn 24, Issue 5, 2009, Pages 371-379

  Garavalia, Linda ^a   Garavalia, Brian ^b   Spertus, John A ^b   Decker, Carole ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

Adherence; Heart medications; Qualitative research; Secondary prevention

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; TICLOPIDINE;

AGED; ARTICLE; ECONOMICS; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MOTIVATION; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; QUALITATIVE RESEARCH; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICS; UNITED STATES; VERBAL COMMUNICATION;

AGED; ANTICHOLESTEREMIC AGENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; MOTIVATION; MYOCARDIAL INFARCTION; NARRATION; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; PATIENT EDUCATION AS TOPIC; PLATELET AGGREGATION INHIBITORS; QUALITATIVE RESEARCH; QUESTIONNAIRES; RISK ASSESSMENT; TICLOPIDINE; UNITED STATES;

EID: 70349114260     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e3181ae7b2a     Document Type: Article

References (35)

1. Peters RJ, Mehta SR, Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidog-rel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation. 2003;108: 1682-1687.
2. Moriel M, Tzivoni D, Behar S, et al. Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes. Int J Cardiol. 2008;131: 97 Y104.
3. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363-2372.
4. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113: 203-212.
5. Evangelista LS, Dracup K. A closer look at compliance research in heart failure patients in the last decade. Prog Cardiovasc Nurs. 2000;15:97-103.
6. Sud A, Kline-Rogers EM, Eagle KA, et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39:1792-1797.
7. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. Bmj. 2000;321:983-986.
8. Ross SD, Allen IE, Connelly JE, et al. Clinical outcomes in statin treatment trials: a meta-analysis. Arch Intern Med. 1999;159:1793-1802.
9. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocar-dial infarction. Arch Intern Med. 2006;166:1842-1847.
10. Andrade SE, Walker AM, Gottlieb LK, et al. Discontinuation of antihyperlipidemic drugsVdo rates reported in clinical trials reflect rates in primary care settings? N Engl J Med. 1995;332:1125-1131.
11. Simons LA, Levis G, Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust. 1996;164:208-211.
12. Brookhart MA, Patrick AR, Schneeweiss S, et al. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007;167:847-852.
13. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19:638-645.
14. McGinnis B, Olson KL, Magid D, et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007;41: 1805-1811.
15. Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117:73-81.
16. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813-818.
17. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006; 113:2803-2809.
18. Albert NM. Improving medication adherence in chronic cardiovascular disease. Crit Care Nurse. 2008;28:54-64; quiz, p65.
19. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166:1855-1862.
20. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297:831-841.
21. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
22. Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005;165:1842-1847.
23. Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long-term adherence with cardiovascular drug regimens. Am Heart J. 2006;151:185-191.
24. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002;36:1532-1539.
25. Fincham J. Patient Compliance With Medications: Issues and Opportunities. New York, NY: Haworth Press Inc; 2007.
26. Becker MH. The Health Belief Model and sick role behavior. Health Educ Monogr. 1974;2:409-419.
27. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11:1-47.
28. Sandelowski M, Barroso J. Writing the proposal for a qualitative research methodology project. Qual Health Res. 2003;13:781-820.
29. Breakwell GM. Interviewing methods. In: Breakwell G, Hammond S, Fife-Schaw C, Smith J, eds. Research Methods in Psychology. 3rd ed. Los Angeles, CA: Sage Publications; 2006:232-253.
30. Davidson MH, Robinson JG. Safety of aggressive lipid management. J Am Coll Cardiol. 2007;49:1753-1762.
31. Berra K. Lipid-lowering therapy today: treating the high-risk cardiovascular patient. J Cardiovasc Nurs. 2008;23: 414-421.
32. Cheng JW, Kalis MM, Feifer S. Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Pharmacotherapy. 2001;21:828-841.
33. Decker C, Garavalia L, Chen C, et al. Acute myocar-dial infarction patients' information needs over the course of treatment and recovery. J Cardiovasc Nurs. 2007;22: 459-465.
34. Rhee SJ, Yun KH, Lee SR, et al. Drug-eluting stent thrombosis during perioperative period. Int Heart J. 2008;49: 135-142.
35. Evangelista LS, Shinnick MA. What do we know about adherence and self-care? J Cardiovasc Nurs. 2008;23:250-257.